Bayer plans $10.5 billion settlement for Roundup cancer lawsuits

The German chemical giant aims to resolve current and future legal claims regarding its weedkiller. This massive plan includes a major class-action settlement.

洞察:
Bayer AG , headquartered in Germany DEDE, is planning to announce a $10.5 billion settlement plan to resolve current and potential future cancer lawsuits in the United States USUS tied to its Roundup (herbicide). The proposal, which is currently under discussion, would include a $7.5 billion class-action settlement designed to cover suits filed in Missouri state court over a 20-year period and $3 billion to settle existing U.S. cases. If implemented, the move would alter the litigation exposure and financial liabilities of the company related to Roundup claims.
The 120-meter-high Bayer Cross, the logo of German pharmaceutical and chemical manufacturer Bayer AG consisting of 1,710 LED glass bulbs, is seen next to a red traffic light in Leverkusen, Germany, on September 23, 2023. REUTERS/Wolfgang Rattay
The 120-meter-high Bayer Cross, the logo of German pharmaceutical and chemical manufacturer Bayer AG consisting of 1,710 LED glass bulbs, is seen next to a red traffic light in Leverkusen, Germany, on September 23, 2023. REUTERS/Wolfgang Rattay
IUX24

IUX24 提供深度財經、經濟與投資資訊,借助 AI 挖掘全球市場中最重要的訊號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場資料、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易訊號或經紀服務。投資涉及風險,使用者在做出投資決定前應審慎評估相關資訊。